FDC Ltd 531599
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹544.80
- Day Range
- ₹535.45–551.10
- 52-Week Range
- ₹344.00–659.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹87.89 Bil
- Volume/Avg
- 11,365 / 34,156
Key Statistics
- Price/Earnings (Normalized)
- 32.92
- Price/Sales
- 4.37
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 1.75%
Company Profile
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 6,777
- Website
- https://www.fdcindia.com
Comparables
Valuation
|
Metric
|
531599
|
532815
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.92 | 52.55 | 34.56 |
Price/Book Value | 4.23 | 5.91 | 5.81 |
Price/Sales | 4.37 | 4.08 | 8.09 |
Price/Cash Flow | 37.18 | 36.20 | 36.48 |
Price/Earnings
531599
532815
543434
Financial Strength
|
Metric
|
531599
|
532815
|
543434
|
|---|---|---|---|
Quick Ratio | 1.93 | 0.86 | 2.47 |
Current Ratio | 3.43 | 1.61 | 5.17 |
Interest Coverage | 103.33 | 4.55 | 51.09 |
Quick Ratio
531599
532815
543434
Profitability
|
Metric
|
531599
|
532815
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
531599
532815
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Czzzmygkjj | Bvnv | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Dttpgfwltq | Vkdkjz | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Vbfyyvrxd | Gvjc | $48.4 Bil | |||
| Viatris Inc
VTRS
| Qpynjwwp | Hxjk | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fzltkzp | Fcpm | $13.5 Bil | |||
| Catalent Inc
CTLT
| Bkwjyjf | Yrcwhn | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Rnvmqdn | Gvprsx | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Vwwlyzv | Lhjqd | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Pskblymmft | Jfw | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Ypnnsnm | Mxy | $2.3 Bil |
United States